(Q28236372)

2

0 references

Mark Stoopler

3

0 references

Mark Ginsburg

4

0 references

Lyall Gorenstein

5

0 references

Joshua R Sonett

6

0 references

Charles A Powell

7

0 references

language of work or name

English

0 references

publication date

15 May 2011

0 references

published in

Cancer

0 references

volume

117

0 references

page(s)

2186-91

0 references

issue

10

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Epidemiology of Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Multidisciplinary management of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Invasive size is an independent predictor of survival in pulmonary adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Lysyl oxidase: an oxidative enzyme and effector of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Paradoxical roles for lysyl oxidases in cancer--a prospect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Intracellular localization of the matrix enzyme lysyl oxidase in polarized epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Localization and activity of lysyl oxidase within nuclei of fibrogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Tumor stroma and regulation of cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Stromal gene expression predicts clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768

Disease recurrence after resection for stage I lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25768